Royalty Pharma
Price & Volume
Stats
See more52W Range | $33.97-$64.38 |
Market Cap | $33.8B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $2.5B |
Revenue Growth (YoY) | 16.5% |
Gross Profit (12 Mos) | $2.4B |
Diluted EPS | $1.86 |
News
See moreYahoo Finance • 12 days ago
Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focus
Yahoo Finance • 15 days ago
Royalty Pharma (RPRX): Can Downside Protection Offset Pelacarsen’s Phase 3 Failure?
Yahoo Finance • 21 days ago
Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen
Yahoo Finance • last month
Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story?
About
CEO | Mr. Pablo Legorreta |
CFO | Mr. Terrance P. Coyne |
Address | 110 East 59th Street, New York, NY, United States, 10022 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |